Early detection and serial monitoring during chemotherapy-radiation therapy: using t1 and t2 mapping cardiac magnetic resonance imaging

HIGHLIGHTS

• who: Yaotian Tian and colleagues from the All patients who received chest radiotherapy at our institution from March , to September , were included in this prospective studyExclusion criteria included younger than , years old and older than , years, inappropriate irradiation field (whole heart exposed to radiation field or not exposed to radiation field), receiving anthracycline chemotherapy, and having known cardiac symptoms or diseases (organic heart disease, hypertension, coronary artery disease, etc.). Finally, our prospective observational study included , consecutive patients who received non-anthracycline chemotherapy and chest radiotherapy and , healthy controls with matched age and gender. To evaluate the changes . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.